Matches in Wikidata for { <http://www.wikidata.org/entity/Q106637650> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q106637650 description "clinical trial" @default.
- Q106637650 description "ensayo clínico" @default.
- Q106637650 description "ensayu clínicu" @default.
- Q106637650 description "klinisch onderzoek" @default.
- Q106637650 description "клінічне випробування" @default.
- Q106637650 description "կլինիկական փորձարկում" @default.
- Q106637650 description "临床试验" @default.
- Q106637650 name "Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)" @default.
- Q106637650 name "Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)" @default.
- Q106637650 type Item @default.
- Q106637650 label "Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)" @default.
- Q106637650 label "Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)" @default.
- Q106637650 prefLabel "Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)" @default.
- Q106637650 prefLabel "Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)" @default.
- Q106637650 P1050 Q106637650-144435C1-3F33-4633-8440-4D7B70DE9D43 @default.
- Q106637650 P1132 Q106637650-00C3B0B8-EA43-4E94-9CB2-884A0C80E93E @default.
- Q106637650 P1476 Q106637650-9E4B169B-42B9-408A-98EB-699F39F20773 @default.
- Q106637650 P17 Q106637650-0A5AA5D9-F078-4DA4-A8CC-5399074B7E40 @default.
- Q106637650 P2899 Q106637650-C0AC8E85-0FCF-4B50-ADEB-D8DCEB9B6E78 @default.
- Q106637650 P3098 Q106637650-9277F5D5-EB5E-4EDC-9573-019A884E7F1F @default.
- Q106637650 P31 Q106637650-13E0E980-99B5-4CDA-9CCB-2D26C9658FB4 @default.
- Q106637650 P580 Q106637650-352ACFFE-3C19-4887-B423-540609DCD7A1 @default.
- Q106637650 P582 Q106637650-25547CE3-465C-4E03-B67F-15B4C730B077 @default.
- Q106637650 P6099 Q106637650-F5EC2A77-C114-498F-8FD0-8E71A4E12C8A @default.
- Q106637650 P6153 Q106637650-302A50CC-D7E5-42D7-A895-31E24F7B51A7 @default.
- Q106637650 P6153 Q106637650-A89BE504-36A9-43AA-B66E-F97D55E423C0 @default.
- Q106637650 P8005 Q106637650-920C9ABF-E1F6-4391-9229-EC991D96C38A @default.
- Q106637650 P8363 Q106637650-3C042A46-1580-4859-BE39-DF8E5CF9C88F @default.
- Q106637650 P859 Q106637650-D2ED8271-D2E5-486C-8DFC-CC0A62391A83 @default.
- Q106637650 P1050 Q223911 @default.
- Q106637650 P1132 "+48" @default.
- Q106637650 P1476 "Phase 2 Study of Rogaratinib (BAY 1163877) in the Treatment of Patients With Sarcoma Harboring Alterations in Fibroblast Growth Factor Receptor (FGFR) 1-4 and SDH-Deficient Gastrointestinal Stromal Tumor (GIST)" @default.
- Q106637650 P17 Q30 @default.
- Q106637650 P2899 "+18" @default.
- Q106637650 P3098 "NCT04595747" @default.
- Q106637650 P31 Q30612 @default.
- Q106637650 P580 "2021-02-01T00:00:00Z" @default.
- Q106637650 P582 "2023-02-05T00:00:00Z" @default.
- Q106637650 P6099 Q42824440 @default.
- Q106637650 P6153 Q1159198 @default.
- Q106637650 P6153 Q1808012 @default.
- Q106637650 P8005 Q76649708 @default.
- Q106637650 P8363 Q78089383 @default.
- Q106637650 P859 Q664846 @default.